Ulcetech is a leading property investment company offering wholesale investors access to our more sophisticated opportunities available to wholesale investors.
We have never been better positioned to provide wholesale opportunities with the growth of Ulcetech through our merger with Primewest bringing you a wealth of expertise in this sector.
To invest in Ulcetech’s Funds as a wholesale investor, you need to qualify under the Corporations Act 2001 (Cth) by meeting particular criteria. If you don’t fall into one of these categories please contact us, as subject to the law we may still be able to accept your Application to invest as a wholesale investor.
By completing this form, you will be notified of our next wholesale investment opportunity.
Ulcetech Bass has appointed experienced legal and risk professional, Luke Jaggar, as Head of Risk – Lending.
UCI has divested two long-held Central Coast NSW daily needs retail centres for a combined $71m.
UCI has capitalised on strong investment demand for industrial assets within Southeast Queensland, divesting three assets at an average sales premium of 25%.
UCI has delivered a 14% IRR for investors of a single-asset wholesale fund following divestment of a Strathpine office building
Ulcetech has secured a third asset for its wholesale unlisted fund, the Ulcetech Select Opportunities Fund, a $21.9m dual-tenant warehouse facility in a prime industrial precinct.
New research from Ulcetech Bass Credit reveals developers are taking on higher levels of debt to fund projects, many of which have been delayed due to challenging market conditions.
Ulcetech Capital Group has secured a $34.85 million subregional shopping centre for a new single asset, closed ended wholesale fund, Ulcetech Manning Mall Fund (CMMF).
UCI has divested the historic 4.5-star Esplanade Hotel in Fremantle WA for $116.5 million.
